Chapter 104 · Chapter 104 Jaundice, Diarrhea, ... role of ERCP in diseases of the biliary tract...

Chapter 104Jaundice, Diarrhea, Obstruction, and Pseudoobstruction

REFERENCES

1. Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013;19(38): 6398-6407.

2. Ah YM, Kim YM, Kim MJ, et al. Drug-induced hyperbiliru-binemia and the clinical influencing factors. Drug Metab Rev. 2008;40(4):511-537.

3. Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62(1):1-8.

4. Lai EC, Lau WY. Mirizzi syndrome: history, present and future development. ANZ J Surg. 2006;76(4):251-257.

5. Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6(9):533-541.

6. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987;7(5):913-917.

7. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-639.

8. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20(6): 981-996.

9. Reynolds BM, Dargan EL. Acute obstructive cholangitis: a distinct clinical syndrome. Ann Surg. 1959;150(2):299-303.

10. Wada K, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):52-58.

11. Kondo S, Isayama H, Akahane M, et al. Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography. Eur J Radiol. 2005;54(2):271-275.

12. Polkowski M, Palucki J, Regula J, Tilszer A, Butruk E. Helical computed tomographic cholangiography versus endosonogra-phy for suspected bile duct stones: a prospective blinded study in non-jaundiced patients. Gut. 1999;45(5):744-749.

13. Gan SI, Rajan E, Adler DG, et al. Role of EUS. Gastrointest Endosc. 2007;66(3):425-434.

14. Leung JW, Liu YL, Lau GC, et al. Bacteriologic analyses of bile and brown pigment stones in patients with acute cholangitis. Gastrointest Endosc. 2001;54(3):340-345.

15. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002;56(6):885-889.

16. Dasari BV, Tan CJ, Gurusamy KS, et al. Surgical versus endo-scopic treatment of bile duct stones. Cochrane Database Syst Rev. 2013;9:CD003327.

17. Swarnkar K, Stamatakis JD, Young WT. Diagnostic and thera-peutic endoscopic retrograde cholangiopancreaticography after Billroth II gastrectomy—safe provision in a district general hospital. Ann R Coll Surg Engl. 2005;87(4):274-276.

18. Chopra KB, Peters RA, O'Toole PA, et al. Randomised study of endoscopic biliary endoprosthesis versus duct clearance for bileduct stones in high-risk patients. Lancet. 1996;348(9030): 791-793.

19. Williams EJ, Green J, Beckingham I, Parks R, Martin D, Lombard M. Guidelines on the management of common bile duct stones (CBDS). Gut. 2008;57(7):1004-1021.

20. McAlister VC, Davenport E, Renouf E. Cholecystectomy defer-ral in patients with endoscopic sphincterotomy. Cochrane Database Syst Rev. 2007;(4):CD006233.

21. Knab LM, Boller AM, Mahvi DM. Cholecystitis. Surg Clin North Am. 2014;94(2):455-470.

22. Simorov A, Ranade A, Parcells J, et al. Emergent cholecys-tostomy is superior to open cholecystectomy in extremely ill patients with acalculous cholecystitis: a large multicenter out-come study. Am J Surg. 2013;206(6):935-940.

23. Chung YH, Choi ER, Kim KM, et al. Can percutaneous cho-lecystostomy be a definitive management for acute acalculous cholecystitis? J Clin Gastroenterol. 2012;46(3):216-219.

24. Chung C, Buchman AL. Postoperative jaundice and total par-enteral nutrition-associated hepatic dysfunction. Clin Liver Dis. 2002;6(4):1067-1084.

25. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21(3):279-290.

26. Collins JD, Bassendine MF, Ferner R, et al. Incidence and prog-nostic importance of jaundice after cardiopulmonary bypass surgery. Lancet. 1983;1(8334):1119-1123.

27. Gilroy RK, Mailliard ME, Gollan JL. Gastrointestinal disorders of the critically ill. Cholestasis of sepsis. Best Pract Res Clin Gastroenterol. 2003;17(3):357-367.

Section09-O-Ref.indd 1 12/10/2014 6:09:23 PM

References2

28. Wojcicki M, Milkiewicz P, Silva M. Biliary tract complica-tions after liver transplantation: a review. Dig Surg. 2008;25(4): 245-257.

29. Wojcicki M, Silva MA, Jethwa P, et al. Biliary complications fol-lowing adult right lobe ex vivo split liver transplantation. Liver Transpl. 2006;12(5):839-844.

30. Strassburg CP. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol. 2003;17(3): 369-381.

31. Gungabissoon U, Hacquoil K, Bains C, et al. Prevalence, risk fac-tors, clinical consequences, and treatment of enteral feed intoler-ance during critical illness. JPEN J Parenter Enteral Nutr. March 17, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24637246.

32. Montejo JC. Enteral nutrition-related gastrointestinal com-plications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med. 1999;27(8):1447-1453.

33. Reintam A, Parm P, Kitus R, Kern H, Starkopf J. Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand. 2009;53(3):318-324.

34. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33(3):277-316.

35. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27(5):355-373.

36. Dupont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92(11):1962-1975.

37. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA. 1990;263(7):979-982.

38. van der Spoel JI, Schultz MJ, van der Voort PH, de JE. Influence of severity of illness, medication and selective decontamination on defecation. Intensive Care Med. 2006;32(6):875-880.

39. Ferrie S, East V. Managing diarrhoea in intensive care. Aust Crit Care. 2007;20(1):7-13.

40. Hyams JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology. 1983;84(1):30-33.

41. Barrett JS, Shepherd SJ, Gibson PR. Strategies to manage gas-trointestinal symptoms complicating enteral feeding. JPEN J Parenter Enteral Nutr. 2009;33(1):21-26.

42. Btaiche IF, Chan LN, Pleva M, Kraft MD. Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients. Nutr Clin Pract. 2010;25(1):32-49.

43. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.

44. Dupont HL, Flores SJ, Ericsson CD, et al. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in

the management of acute diarrhea. Am J Med. 1990;88(6A): 15S-19S.

45. Taylor NS, Bartlett JG. Binding of Clostridium difficile cyto-toxin and vancomycin by anion-exchange resins. J Infect Dis. 1980;141(1):92-97.

46. Parrish CR. Enteral feeding: the art and the science. Nutr Clin Pract. 2003;18(1):76-85.

47. Sabol VK, Carlson KK. Diarrhea: applying research to bedside practice. AACN Adv Crit Care. 2007;18(1):32-44.

48. Halmos EP. Role of FODMAP content in enteral nutrition- associated diarrhea. J Gastroenterol Hepatol. 2013;28(suppl 4): 25-28.

49. Beyer PL, Caviar EM, McCallum RW. Fructose intake at current levels in the United States may cause gastrointestinal distress in normal adults. J Am Diet Assoc. 2005;105(10):1559-1566.

50. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malab-sorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009;30(2):165-174.

51. McKee LH, Latner TA. Underutilized sources of dietary fiber: a review. Plant Foods Hum Nutr. 2000;55(4):285-304.

52. Schneider SM, Girard-Pipau F, Anty R, et al. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin Nutr. 2006;25(1):82-90.

53. Elia M, Engfer MB, Green CJ, Silk DB. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther. 2008;27(2):120-145.

54. Yang G, Wu XT, Zhou Y, Wang YL. Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized con-trolled trials. World J Gastroenterol. 2005;11(25):3935-3938.

55. Wiesen P, Van GA, Preiser JC. Diarrhoea in the critically ill. Curr Opin Crit Care. 2006;12(2):149-154.

56. Isakow W, Morrow LE, Kollef MH. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest. 2007;132(1):286-294.

57. Shang E, Geiger N, Sturm JW, Post S. Pump-assisted versus gravity-controlled enteral nutrition in long-term percutaneous endoscopic gastrostomy patients: a prospective controlled trial. JPEN J Parenter Enteral Nutr. 2003;27(3):216-219.

58. Steevens EC, Lipscomb AF, Poole GV, Sacks GS. Comparison of continuous vs intermittent nasogastric enteral feeding in trauma patients: perceptions and practice. Nutr Clin Pract. 2002;17(2):118-122.

59. Larson HE, Price AB, Honour P, Borriello SP. Clostridium dif-ficile and the aetiology of pseudomembranous colitis. Lancet. 1978;1(8073):1063-1066.

60. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathoge-nicity of Clostridium difficile in hospitalized patients: a French multicenter study. Arch Intern Med. 1996;156(13):1449-1454.

61. Lamontagne F, Labbe AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267-272.

62. Alvarez-Lerma F, Palomar M, Villasboa A, et al. Epidemiological study of Clostridium difficile infection in critical patients admitted to the intensive care unit. Med Intensiva. February 3, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24503331.


References 3

63. Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol. 2014;30(1):54-62.

64. Poutanen SM, Simor AE. Clostridium difficile-associated diar-rhea in adults. CMAJ. 2004;171(1):51-58.

65. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441.

66. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with out-breaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079-1084.

67. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-2449.

68. McFee RB, Abdelsayed GG. Clostridium difficile. Dis Mon. 2009;55(7):439-470.

69. Tonna I, Welsby PD. Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J. 2005;81(956):367-369.

70. Noblett SE, Welfare M, Seymour K. The role of surgery in Clostridium difficile colitis. BMJ. 2009;338:b1563.

71. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(suppl 2):1-26.

72. Dallas KB, Condren A, Divino CM. Life after colectomy for fulminant Clostridium difficile colitis: a 7-year follow up study. Am J Surg. 2014;207(4):533-539.

73. Musher DM, Aslam S. Treatment of Clostridium difficile colitis in the critical care setting. Crit Care Clin. 2008;24(2): 279-291, viii.

74. Musher DM, Manhas A, Jain P, et al. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol. 2007;45(8):2737-2739.

75. Nelson RL, Kelsey P, Leeman H, et al. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2011;(9):CD004610.

76. Musher DM, Logan N, Hamill RJ, et al. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006;43(4):421-427.

77. Marchese A, Salerno A, Pesce A, Debbia EA, Schito GC. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species. Chemotherapy. 2000;46(4):253-266.

78. Lancaster JW, Matthews SJ. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections. Clin Ther. 2012;34(1):1-13.

79. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious DiseasesESCMID): treat-ment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15(12):1067-1079.

80. Ali SO, Welch JP, Dring RJ. Early surgical intervention for fulminant pseudomembranous colitis. Am Surg. 2008; 74(1):20-26.

81. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004;47(10):1620-1626.

82. Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8(2):149-154.

83. Seltman AK. Surgical management of Clostridium difficile colitis. Clin Colon Rectal Surg. 2012;25(4):204-209.

84. Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage: an alterna-tive to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423-427.

85. Parker MC, Ellis H, Moran BJ, et al. Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdom-inal surgery. Dis Colon Rectum. 2001;44(6):822-829.

86. Diaz JJ, Jr., Bokhari F, Mowery NT, et al. Guidelines for management of small bowel obstruction. J Trauma. 2008;64(6): 1651-1664.

87. Kim JH, Ha HK, Kim JK, et al. Usefulness of known computed tomography and clinical criteria for diagnosing strangulation in small-bowel obstruction: analysis of true and false inter-pretation groups in computed tomography. World J Surg. 2004;28(1):63-68.

88. Ballantyne GH. Review of sigmoid volvulus. Clinical patterns and pathogenesis. Dis Colon Rectum. 1982;25(8):823-830.

89. Chapman AH, McNamara M, Porter G. The acute contrast enema in suspected large bowel obstruction: value and tech-nique. Clin Radiol. 1992;46(4):273-278.

90. Moore CJ, Corl FM, Fishman EK. CT of cecal volvulus: unravel-ing the image. AJR Am J Roentgenol. 2001;177(1):95-98.

91. Lal SK, Morgenstern R, Vinjirayer EP, Matin A. Sigmoid volvulus an update. Gastrointest Endosc Clin N Am. 2006;16(1): 175-187.

92. Watt AM, Faragher IG, Griffin TT, Rieger NA, Maddern GJ. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg. 2007;246(1):24-30.

93. Masci E, Viale E, Mangiavillano B, et al. Enteral self-expandable metal stent for malignant luminal obstruction of the upper and lower gastrointestinal tract: a prospective multicentric study. J Clin Gastroenterol. 2008;42(4):389-394.

94. Schwab DP, Blackhurst DW, Sticca RP. Operative acute small bowel obstruction: admitting service impacts outcome. Am Surg. 2001;67(11):1034-1038.

95. Sarr MG, Bulkley GB, Zuidema GD. Preoperative recognition of intestinal strangulation obstruction: prospective evaluation of diagnostic capability. Am J Surg. 1983;145(1):176-182.

96. Bauer AJ, Schwarz NT, Moore BA, Turler A, Kalff JC. Ileus in critical illness: mechanisms and management. Curr Opin Crit Care. 2002;8(2):152-157.

97. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med. 1996;334(17):1106-1115.

98. Luckey A, Livingston E, Tache Y. Mechanisms and treatment of postoperative ileus. Arch Surg. 2003;138(2):206-214.

99. Asao T, Kuwano H, Nakamura J, Morinaga N, Hirayama I, Ide M. Gum chewing enhances early recovery from postop-erative ileus after laparoscopic colectomy. J Am Coll Surg. 2002;195(1):30-32.


References4

100. Fitzgerald JE, Ahmed I. Systematic review and meta-analysis of chewing-gum therapy in the reduction of postoperative paralytic ileus following gastrointestinal surgery. World J Surg. 2009;33(12):2557-2566.

101. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet. 2002;359(9320): 1812-1818.

102. Rahbari NN, Zimmermann JB, Schmidt T, Koch M, Weigand MA, Weitz J. Meta-analysis of standard, restrictive and supple-mental fluid administration in colorectal surgery. Br J Surg. 2009;96(4):331-341.

103. Lassen K, Soop M, Nygren J, et al. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg. 2009;144(10):961-969.

104. Jorgensen H, Wetterslev J, Moiniche S, Dahl JB. Epidural local anaesthetics versus opioid-based analgesic regimens on postop-erative gastrointestinal paralysis, PONV and pain after abdomi-nal surgery. Cochrane Database Syst Rev. 2000;(4):CD001893.

105. Delaney CP, Wolff BG, Viscusi ER, et al. Alvimopan, for post-operative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg. 2007;245(3):355-363.

106. Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet. 2009;373(9670):1198-1206.

107. Lightfoot AJ, Eno M, Kreder KJ, O’Donnell MA, Rao SS, Williams RD. Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin. Urology. 2007;69(4):611-615.

108. Smith AJ, Nissan A, Lanouette NM, et al. Prokinetic effect of erythromycin after colorectal surgery: randomized, placebo- controlled, double-blind study. Dis Colon Rectum. 2000;43(3):333-337.

109. Cheape JD, Wexner SD, James K, Jagelman DG. Does metoclopramide reduce the length of ileus after colorectal surgery? A prospective randomized trial. Dis Colon Rectum. 1991;34(6):437-441.

110. Ogilvie H. Large-intestine colic due to sympathetic depri-vation: a new clinical syndrome. Br Med J. 1948;2(4579): 671-673.

111. Nanni G, Garbini A, Luchetti P, Nanni G, Ronconi P, Castagneto M. Ogilvie’s syndrome (acute colonic pseudo-obstruction): review of the literature (October 1948 to March 1980) and report of four additional cases. Dis Colon Rectum. 1982;25(2):157-166.

112. Saunders MD. Acute colonic pseudo-obstruction. Best Pract Res Clin Gastroenterol. 2007;21(4):671-687.

113. Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie’s syndrome): an analysis of 400 cases. Dis Colon Rectum. 1986;29(3):203-210.

114. Norwood MG, Lykostratis H, Garcea G, Berry DP. Acute colonic pseudo-obstruction following major orthopaedic sur-gery. Colorectal Dis. 2005;7(5):496-499.

115. Wegener M, Borsch G. Acute colonic pseudo-obstruction (Ogilvie’s syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature. Surg Endosc. 1987;1(3):169-174.

116. Jain A, Vargas HD. Advances and challenges in the management of acute colonic pseudo-obstruction (ogilvie syndrome). Clin Colon Rectal Surg. 2012;25(1):37-45.

117. Beattie GC, Peters RT, Guy S, Mendelson RM. Computed tomography in the assessment of suspected large bowel obstruc-tion. ANZ J Surg. 2007;77(3):160-165.

118. Johnson CD, Rice RP, Kelvin FM, Foster WL, Williford ME. The radiologic evaluation of gross cecal distension: emphasis on cecal ileus. AJR Am J Roentgenol. 1985;145(6):1211-1217.

119. De GR, Knowles CH. Acute colonic pseudo-obstruction. Br J Surg. 2009;96(3):229-239.

120. Harrison ME, Anderson MA, Appalaneni V, et al. The role of endoscopy in the management of patients with known and suspected colonic obstruction and pseudo-obstruction. Gastrointest Endosc. 2010;71(4):669-679.

121. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999;341(3):137-141.

122. van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure–a prospective, double-blind, placebo-controlled trial. Intensive Care Med. 2001;27(5):822-827.

123. Sgouros SN, Vlachogiannakos J, Vassiliadis K, et al. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut. 2006;55(5):638-642.

124. Harvey KP, Adair JD, Isho M, Robinson R. Can intravenous lidocaine decrease postsurgical ileus and shorten hospital stay in elective bowel surgery? A pilot study and literature review. Am J Surg. 2009;198(2):231-236.

125. Baumann A, Audibert G, Klein O, Mertes PM. Continuous intravenous lidocaine in the treatment of paralytic ileus due to severe spinal cord injury. Acta Anaesthesiol Scand. 2009;53(1): 128-130.

126. Kling N. Naloxone in opiate-induced colonic pseudo- obstruction. S Afr Med J. 1991;79(1):53.

127. Portenoy RK, Thomas J, Moehl Boatwright ML, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage. 2008;35(5):458-468.

128. Rex DK. Acute colonic pseudo-obstruction (Ogilvie’s syn-drome). Gastroenterologist. 1994;2(3):233-238.

129. Harig JM, Fumo DE, Loo FD, et al. Treatment of acute nontoxic megacolon during colonoscopy: tube placement versus simple decompression. Gastrointest Endosc. 1988;34(1):23-27.

130. Nano D, Prindiville T, Pauly M, Chow H, Ross K, Trudeau W. Colonoscopic therapy of acute pseudo obstruction of the colon. Am J Gastroenterol. 1987;82(2):145-148.

131. Cowlam S, Watson C, Elltringham M, et al. Percutaneous endoscopic colostomy of the left side of the colon. Gastrointest Endosc. 2007;65(7):1007-1014.

132. Chevallier P, Marcy PY, Francois E, et al. Controlled transperi-toneal percutaneous cecostomy as a therapeutic alternative to the endoscopic decompression for Ogilvie's syndrome. Am J Gastroenterol. 2002;97(2):471-474.


References 5

133. Crass JR, Simmons RL, Frick MP, Maile CW. Percutaneous decompression of the colon using CT guidance in Ogilvie syndrome. AJR Am J Roentgenol. 1985;144(3):475-476.

134. Salm R, Ruckauer K, Waldmann D, Farthmann EH. Endoscopic percutaneous cecostomy (EPC). Surg Endosc. 1988;2(2):92-95.

135. vanSonnenberg E, Varney RR, Casola G, et al. Percutaneous cecostomy for Ogilvie syndrome: laboratory observations and clinical experience. Radiology. 1990;175(3):679-682.

136. Ramage JI Jr, Baron TH. Percutaneous endoscopic cecostomy: a case series. Gastrointest Endosc. 2003;57(6):752-755.

137. Lynch CR, Jones RG, Hilden K, Wills JC, Fang JC. Percutaneous endoscopic cecostomy in adults: a case series. Gastrointest Endosc. 2006;64(2):279-282.


Chapter 105Gastrointestinal HemorrhageRam Subramanian

REFERENCES

1. Zhao Y, Encinosa W. Hospitalizations for Gastrointestinal Bleeding in 1998 and 2006. HCUP Statistical Brief #65, December 2008. Rockville, MD: Agency for Healthcare Research and Quality; 2008.

2. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008;359(9): 928-937.

3. Farrell JJ, Friedman LS. Gastrointestinal bleeding in older people. Gastroenterol Clin North Am. 2000;29(1):1-36, v.

4. Lim CH, et al. The outcome of suspected upper gastrointes-tinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study. Endoscopy. 2006;38(6): 581-585.

5. Lewis JD, et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol. 2002;97(10):2540-2549.

6. Barkun A, et al. The canadian registry on nonvariceal upper gastrointestinal bleeding and endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99(7):1238-1246.

7. Kollef MH, et al. BLEED: a classification tool to predict out-comes in patients with acute upper and lower gastrointestinal hemorrhage. Crit Care Med. 1997;25(7):1125-1132.

8. Rockall TA, et al. Risk assessment after acute upper gastrointes-tinal haemorrhage. Gut. 1996;38(3):316-321.

9. Corley DA, et al. Early indicators of prognosis in upper gastro-intestinal hemorrhage. Am J Gastroenterol. 1998;93(3):336-340.

10. Kuipers EJ. Endoscopy: risk assessment in upper gastrointesti-nal bleeding. Nat Rev Gastroenterol Hepatol. 2010;7(9):480-482.

11. Velayos FS, et al. Early predictors of severe lower gastrointes-tinal bleeding and adverse outcomes: a prospective study. Clin Gastroenterol Hepatol. 2004;2(6):485-490.

12. Strate LL, Orav EJ, Syngal S. Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med. 2003;163(7):838-843.

13. Strate LL, et al. Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol. 2005;100(8):1821-1827.

14. Cuellar RE, et al. Gastrointestinal tract hemorrhage. The value of a nasogastric aspirate. Arch Intern Med. 1990;150(7): 1381-1384.

15. Palamidessi N, et al. Nasogastric aspiration and lavage in emergency department patients with hematochezia or melena without hematemesis. Acad Emerg Med. 2010;17(2):126-132.

16. Barkun AN. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152:101-113.

17. Jensen DM, Machicado GA. Colonoscopy for diagnosis and treatment of severe lower gastrointestinal bleeding: routine outcomes and cost analysis. Gastrointest Endosc Clin N Am. 1997;7(3):477-498.

18. Jensen DM. et al. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N Engl J Med. 2000;342(2):78-82.

19. Laine L, Shah A. Randomized trial of urgent vs. elective colo-noscopy in patients hospitalized with lower GI bleeding. Am J Gastroenterol. 2010;105(12):2636-2641.

20. Frossard JL, et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology. 2002;123(1):17-23.

21. Barkun AN, Bardou M, Gralnek IM. W1017 erythromycin and other prokinetics in acute upper gastrointestinal bleeding? A meta-analysis. Gastroenterology. 2009;136(5 suppl 1):A-636.

22. Lau JY, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343(5):310-316.

23. Ejlersen E, et al. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol. 2001;36(10):1081-1085.

24. Negrier C, Lienhart A. Overall experience with NovoSeven. Blood Coagul Fibrinolysis. 2000;11(suppl 1):S19-S24.

25. Bosch J, et al. Recombinant factor VIIa for upper gastrointesti-nal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology. 2004;127(4):1123-1130.

26. Bosch J, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47(5):1604-1614.


References2

27. Rostykus PS, McDonald GB, Albert RK. Upper intestinal endoscopy induces hypoxemia in patients with obstructive pulmonary disease. Gastroenterology. 1980;78(3):488-491.

28. Vlavianos P, et al. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond). 1999;96(5):475-481.

29. Chavez-Tapia NC, et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;9:CD002907.

30. Chavez-Tapia NC, et al. The molecular basis of susceptibility to infection in liver cirrhosis. Curr Med Chem. 2007;14(28): 2954-2958.

31. Goulis J, Patch D, Burroughs AK. Bacterial infection in the patho-genesis of variceal bleeding. Lancet. 1999;353(9147):139-142.

32. Goulis J, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gas-trointestinal hemorrhage. Hepatology. 1998;27(5):1207-1212.

33. Javier F, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131(4):1049-1056.

34. Colomo A, Hernandez-Gea V, Muniz-Diaz E, et al. Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding. Hepatology. 2008;48(S1):232.

35. Villanueva C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21.

36. Hebert PC, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409-417.

37. Corley DA, et al. Octreotide for acute esophageal variceal bleed-ing: a meta-analysis. Gastroenterology. 2001;120(4):946-954.

38. Escorsell A, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute vari-ceal bleeding: the TEST study. Hepatology. 2000;32(3):471-476.

39. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esoph-ageal variceal hemorrhage. Cochrane Database Syst Rev. 2003;(1):CD002147.

40. Abid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial. Am J Gastroenterol. 2009;104(3):617-623.

41. Lo GH, et al. Low-dose terlipressin plus banding ligation ver-sus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices. Gut. 2009;58(9):1275-1280.

42. Laine L, Cook D. Endoscopic ligation compared with sclero-therapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med. 1995;123(4):280-287.

43. Villanueva C, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45(4):560-567.

44. Lo GH, et al. A prospective, randomized trial of butyl cyano-acrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33(5):1060-1064.

45. Tan PC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006;43(4):690-697.

46. Yang WL, et al. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol. 2002;97(6):1381-1385.

47. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126(4):1175-1189.

48. Azoulay D, et al. Salvage transjugular intrahepatic portosys-temic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol. 2001;35(5):590-597.

49. Monescillo A, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40(4):793-801.

50. Garcia-Pagan JC, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25): 2370-2379.

51. Henderson JM, et al. Surgical shunts and TIPS for variceal decompression in the 1990s. Surgery. 2000;128(4):540-547.

52. Henderson JM, et al. Distal splenorenal shunt versus transjugu-lar intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130(6):1643-1651.

53. Hubmann R, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006;38(9): 896-901.

54. Wright G, et al. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc. 2010:71(1):71-78.

55. Cook DJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology. 1992;102(1):139-148.

56. Sacks HS, et al. Endoscopic hemostasis: an effective therapy for bleeding peptic ulcers. JAMA. 1990;264(4):494-499.

57. Lau JY, et al. Omeprazole before endoscopy in patients with gas-trointestinal bleeding. N Engl J Med. 2007;356(16):1631-1640.

58. Bardou M, et al. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther. 2005;21(6):677-686.

59. Kubba AK, Palmer KR. Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer. Br J Surg. 1996;83(4): 461-468.

60. Chung SS, et al. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treat-ment for actively bleeding ulcers. BMJ. 1997;314(7090):1307-1311.

61. Machicado GA, Jensen DM. Thermal probes alone or with epi-nephrine for the endoscopic haemostasis of ulcer haemorrhage. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(3):443-458.

62. Jensen DM, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology. 2002;123(2):407-413.

63. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345-360.

64. Lin HJ, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998;158(1):54-58.

65. Collins R, Langman M. Treatment with histamine H2 antago-nists in acute upper gastrointestinal hemorrhage: implications of randomized trials. N Engl J Med. 1985;313(11):660-666.


References 3

66. Green FW Jr, et al. Effect of acid and pepsin on blood coagu-lation and platelet aggregation. A possible contributor pro-longed gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74(1):38-43.

67. Andriulli A, et al. High- versus low-dose proton pump inhibi-tors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol. 2008;103(12):3011-3018.

68. Songur Y, et al. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding. Eur J Intern Med. 2011;22(2):200-204.

69. Irving JD, Northfield TC. Emergency arteriography in acute gastrointestinal bleeding. Br Med J. 1976;1(6015): 929-931.

70. Sherman LM, Shenoy SS, Cerra FB. Selective intra-arterial vasopressin: clinical efficacy and complications. Ann Surg. 1979;189(3):298-302.

71. Eckstein MR, et al. Gastric bleeding: therapy with intraarte-rial vasopressin and transcatheter embolization. Radiology. 1984;152(3):643-646.

72. Loffroy R, et al. Embolization of acute nonvariceal upper gastro-intestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol. 2010;33(6):1088-1100.

73. Loffroy R, et al. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009;7(5):515-523.

74. Eriksson LG, et al. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006;17(6):959-964.

75. Foster JH, Hickok DF, Dunphy JE. Factors influencing mortality following emergency operation for massive upper gastrointesti-nal hemorrhage. Surg Gynecol Obstet. 1963;117:257-262.

76. Laine LA. Helicobacter pylori and complicated ulcer disease. Am J Med. 1996;100(5A):52S-57S; discussion 57S-59S.

77. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808-1825.

78. Schuman BM, Threadgill ST. The influence of liver disease and portal hypertension on bleeding in Mallory-Weiss syndrome. J Clin Gastroenterol. 1994;18(1):10-12.

79. Steinert D, Masand-Rai A. Successful combination endoscopic therapy for duodenal Dieulafoy's lesion. Am J Gastroenterol. 1996;91(4):818-819.

80. Matsui S, et al. Endoscopic band ligation for control of nonvari-ceal upper GI hemorrhage: comparison with bipolar electroco-agulation. Gastrointest Endosc. 2002;55(2):214-218.

81. Mumtaz R, Shaukat M, Ramirez FC. Outcomes of endo-scopic treatment of gastroduodenal Dieulafoy’s lesion with rubber band ligation and thermal/injection therapy. J Clin Gastroenterol. 2003;36(4):310-314.

82. Park CH, et al. A prospective, randomized trial of endo-scopic band ligation versus endoscopic hemoclip placement for bleeding gastric dieulafoy’s lesions. Endoscopy. 2004;36(08): 677-681.

83. Haglund U. Stress ulcers. Scand J Gastroenterol Suppl. 1990;175:27-33.

84. Cook DJ, et al. Risk factors for gastrointestinal bleeding in criti-cally ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330(6):377-381.

85. Zinner MJ, et al. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet. 1981;153(2):214-220.

86. Ledermann HP, et al. Superselective coil embolization in acute gastrointestinal hemorrhage: personal experience in 10 patients and review of the literature. J Vasc Interv Radiol. 1998;9(5): 753-760.

87. Cook D, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med. 1998;338(12):791-797.

88. Barkun AN, et al. Proton pump inhibitors vs. histamine 2 recep-tor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol. 2012;107(4):507-520; quiz 521.

89. Pingleton SK, Hadzima SK. Enteral alimentation and gastroin-testinal bleeding in mechanically ventilated patients. Crit Care Med. 1983;11(1):13-16.

90. Raff T, Germann G, Hartmann B. The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient. Burns. 1997;23(4):313-318.

91. Jensen DM, Machicado GA. Diagnosis and treatment of severe hematochezia: the role of urgent colonoscopy after purge. Gastroenterology. 1988;95(6):1569-1574.

92. Lanas A, et al. Time trends and impact of upper and lower gas-trointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104(7):1633-1641.

93. Davila RE, et al. ASGE Guideline: the role of endoscopy in the patient with lower-GI bleeding. Gastrointest Endosc. 2005;62(5):656-660.

94. Green BT, et al. Urgent colonoscopy for evaluation and manage-ment of acute lower gastrointestinal hemorrhage: a randomized controlled trial. Am J Gastroenterol. 2005;100(11):2395-2402.

95. Cohn SM, et al. Angiography for preoperative evaluation in patients with lower gastrointestinal bleeding: are the benefits worth the risks? Arch Surg. 1998;133(1):50-55.

96. Rossini FP, et al. Emergency colonoscopy. World J Surg. 1989;13(2):190-192.

97. Foutch PG, Zimmerman K. Diverticular bleeding and the pigmented protuberance (sentinel clot): clinical implications, histopathological correlation, and results of endoscopic inter-vention. Am J Gastroenterol. 1996;91(12):2589-2593.

98. Eisen GM, et al. An annotated algorithmic approach to upper gastrointestinal bleeding. Gastrointest Endosc. 2001;53(7): 853-858.

99. Kaltenbach T, et al. Safety and efficacy of colonoscopy to treat diverticular bleeding—long-term outcomes of a large multi-center cohort. Gastrointest Endosc. 2009;69(5):AB113-AB113.

100. Santos JC Jr, et al. Angiodysplasia of the colon: endoscopic diag-nosis and treatment. Br J Surg. 1988;75(3):256-258.

101. Trowers EA, et al. Endoscopic hemorrhoidal ligation: prelimi-nary clinical experience. Gastrointest Endosc. 1998;48(1):49-52.

102. Dusold R, et al. The accuracy of technetium-99m-labeled red cell scintigraphy in localizing gastrointestinal bleeding. Am J Gastroenterol. 1994;89(3):345-348.


References4

103. Ng DA, et al. Predictive value of technetium Tc 99m-labeled red blood cell scintigraphy for positive angiogram in mas-sive lower gastrointestinal hemorrhage. Dis Colon Rectum. 1997;40(4):471-477.

104. Reinus JF, Brandt LJ. Vascular ectasias and diverticulosis. Common causes of lower intestinal bleeding. Gastroenterol Clin North Am. 1994;23(1):1-20.

105. Abbas SM, et al. Clinical variables associated with positive angiographic localization of lower gastrointestinal bleeding. ANZ J Surg. 2005;75(11):953-957.

106. Browder W, Cerise EJ, Litwin MS. Impact of emergency angi-ography in massive lower gastrointestinal bleeding. Ann Surg. 1986;204(5):530-536.

107. Guy GE, et al. Acute lower gastrointestinal hemorrhage: treat-ment by superselective embolization with polyvinyl alcohol particles. AJR Am J Roentgenol. 1992;159(3):521-526.

108. Parkes BM, et al. The management of massive lower gastrointes-tinal bleeding. Am Surg. 1993;59(10):676-678.

109. Foutch PG, Sawyer R, Sanowski RA. Push-enteroscopy for diagnosis of patients with gastrointestinal bleeding of obscure origin. Gastrointest Endosc. 1990;36(4):337-341.

110. Triester SL, et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding. Am J Gastroenterol. 2005;100(11):2407-2418.

111. Hartmann D, et al. A prospective two-center study comparing wireless capsule endoscopy with intraoperative enteroscopy in patients with obscure GI bleeding. Gastrointest Endosc. 2005;61(7):826-832.

112. Rex DK, et al. Enteroclysis in the evaluation of suspected small intestinal bleeding. Gastroenterology. 1989;97(1):58-60.

113. DiSario JA, et al. Enteroscopes. Gastrointest Endosc. 2007;66(5):872-880.

114. Fisher L, et al. The role of endoscopy in the management of obscure GI bleeding. Gastrointest Endosc. 2010;72(3):471-479.

115. Shabana FP, et al. Double-balloon enteroscopy and capsule endos-copy have comparable diagnostic yield in small-bowel disease: a meta-analysis. Clin Gastroenterol Hepatol. 2008;6(6):671-676.

116. Barkin JS, Ross BS. Medical therapy for chronic gastrointestinal bleeding of obscure origin. Am J Gastroenterol. 1998;93(8): 1250-1254.

117. Fagan EA, et al. Treatment of haemobilia by selective arterial embolisation. Gut. 1980;21(6):541-544.

118. Berquist TH, et al. Specificity of 99mTc-pertechnetate in scinti-graphic diagnosis of Meckel’s diverticulum: review of 100 cases. J Nucl Med. 1976;17(6):465-469.


Chapter 106Acute Liver FailureJulia Wendon

REFERENCES

1. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2012;55:965-967.

2. Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74-80.

3. O’Grady JG, Schalm SW, Williams R. Acute liver failure: rede-fining the syndromes. Lancet. 1993;342:273-275.

4. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. Systematic review: acute liver failure—one disease, more than 40 definitions. Alimentary Pharmacol Therapeut. 2012;35:1245-1256.

5. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a pro-spective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954.

6. Myers RP, Shaheen AA, Li B, Dean S, Quan H. Impact of liver disease, alcohol abuse, and unintentional ingestions on the out-comes of acetaminophen overdose. Clin Gastroenterol Hepatol. 2008;6:918-925; quiz 837.

7. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008;359:285-292.

8. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-864, 64 e1.

9. Reuben A, Koch DG, Lee WM, Acute Liver Failure Study G. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065-2076.

10. Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS state-ment: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935-952.

11. Lescot T, Karvellas C, Beaussier M, Magder S. Acquired liver injury in the intensive care unit. Anesthesiology. 2012;117:898-904.

12. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 2012;9:156-166.

13. Mitka M. FDA: Increased HBV reactivation risk with ofatu-mumab or rituximab. JAMA. 2013;310:1664.

14. Hsu C, Hsiung CA, Su IJ, et al. A revisit of prophylactic lami-vudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: a randomized trial. Hepatology. 2008;47:844-853.

15. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141:380-385.

16. Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes follow-ing paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 2012;73:285-294.

17. Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl. 2008;14:25-30.

18. Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cere-bral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47:381-386.

19. Harry R, Auzinger G, Wendon J. The effects of supraphysiologi-cal doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71-77.

20. Parekh NK, Hynan LS, De Lemos J, Lee WM, Acute Liver Failure Study G. Elevated troponin I levels in acute liver fail-ure: is myocardial injury an integral part of acute liver failure? Hepatology. 2007;45:1489-1495.

21. Audimooolam VK, McPhail MJ, Sherwood R, et al. Elevated troponin I and its prognostic significance in acute liver failure. Critical care (London, England). 2012;16:R228.

22. Karvellas CJ, Pink F, McPhail M, et al. Bacteremia, acute physi-ology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med. 2010;38:121-126.

23. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg. 2004;240:216-230.

24. Bernal W, Auzinger G, Wendon J. Prognostic utility of the bilirubin lactate and etiology score. Clin Gastroenterol Hepatol. 2009;7:249; author reply.

25. Bernuau J. Selection for emergency liver transplantation. J Hepatol. 1993;19:486-487.

26. Rutherford A, King LY, Hynan LS, et al. Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology. 2012;143:1237-1243.


Chapter 107

REFERENCES

1. Sharma P, Rakela J. Management of pre-liver transplantation patient—part 2. Liver Transpl. 2005;11(3):249-260.

2. Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2006;22(3):254-262.

3. Ong JP, Mullen KD. Hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2001;13(4):325-334.

4. Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999;222(2):99-112.

5. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy— definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716-721.

6. Han MK, Hyzy R. Advances in critical care management of hepatic failure and insufficiency. Crit Care Med. 2006;34(suppl 9):S225-S231.

7. Murphy N. Diagnosis and management of liver failure in the adult. In Parrillo JE, Dellinger RP, eds. Critical Care Medicine: Principles of Diagnosis and Management in the Adult. Philadelphia, PA: Mosby Elsevier; 2008:1575-1604.

8. Lawrence KR, Klee JA. Rifaximin for the treatment of hepatic encephalopathy. Pharmacotherapy. 2008;28(8):1019-1032.

9. Wong F, Girgrah N, Graba J, et al. The cardiac response to exer-cise in cirrhosis. Gut. 2001;49(2):268-275.

10. Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care. 2008;14(2):189-197.

11. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest. 2001;119(4):1179-1184.

12. International consensus conferences in intensive care medicine: ventilator-associated Lung Injury in ARDS. This official confer-ence report was cosponsored by the American Thoracic Society, The European Society of Intensive Care Medicine, and The Societe de Reanimation de Langue Francaise, and was approved by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 1999;160(6):2118-2124.

13. Ventilation with lower tidal volumes as compared with tra-ditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301-1308.

14. Martinez GP, Barbera JA, Visa J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol. 2001;34(5):651-657.

15. Schmidt GA. Management of the patient with cirrhosis. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care. New York, NY: McGraw-Hill; 2005:1289-1298.

16. Ramsay MA. Portopulmonary hypertension and hepatopulmo-nary syndrome, and liver transplantation. Int Anesthesiol Clin. 2006;44(3):69-82.

17. Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale of two circulations. Chest. 2003;123(2):562-576.

18. Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemody-namics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000;6(4):443-450.

19. Krowka MJ, Frantz RP, McGoon MD, et al. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999;30(3):641-648.

20. Chua R, Keogh A, Miyashita M. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant. 2005;24(4):498-500.

21. Garcia N Jr, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol. 2004;38(1):52-58.

22. Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med. 2003;9(4):261-265.

23. Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310-1318.

24. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrho-sis. International Ascites Club. Hepatology. 1996;23(1):164-176.

25. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospec-tive, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134(5):1360-1368.

26. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087-2107.

27. Sigal SH, Stanca CM, Fernandez J, et al. Restricted use of albumin for spontaneous bacterial peritonitis. Gut. 2007;56(4):597-599.

28. Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepa-torenal syndrome: a randomized study. Gastroenterology. 2008;134(5):1352-1359.

29. Chava SP, Singh B, Zaman MB, et al. Current indications for combined liver and kidney transplantation in adults. Transplant Rev (Orlando). 2009;23(2):111-119.


References2

30. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55(suppl 6):vi1-vi12.

31. Gustot T, Durand F, Lebrec D, et al. Severe sepsis in cirrhosis. Hepatology. 2009;50(6):2022-2033.

32. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.

33. Fernandez J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treat-ment with hydrocortisone on survival. Hepatology. 2006;44(5): 1288-1295.

34. Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5(3):419-424.

35. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and man-agement of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922-938.

36. Abraldes JG, Villanueva C, Banares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48(2):229-236.

37. Villanueva C, Colomo A, Bosch A, et al. Transfusion strate-gies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21.

38. Castaneda B, Morales J, Lionetti R, et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology. 2001;33(4):821-825.

39. Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29(6):1655-1661.

40. Nietsch HH. Management of portal hypertension. J Clin Gastroenterol. 2005;39(3):232-236.

41. Wiesner RH. Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl. 2005;11(3):261-263.

42. Murray KF, Carithers RL Jr. AASLD practice guidelines: eval-uation of the patient for liver transplantation. Hepatology. 2005;41(6):1407-1432.


Chapter 108

REFERENCES

1. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179-1187; e1-3.

2. Fagenholz PJ, Ferna ndez-del Castillo C, Harris NS, Pelletier AJ, Camargo CA Jr. Direct medical costs of acute pancreatitis hos-pitalizations in the United States. Pancreas. 2007;35(4):302-307.

3. van Santvoort HC, Bakker OJ, Bollen TL, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology. 2011;141(4):1254-1263.

4. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1): 102-111.

5. Waldthaler A, Schütte K, Malfertheiner P. Causes and mecha-nisms in acute pancreatitis. Dig Dis. 2010;28(2):364-372.

6. Vaccaro MI. Autophagy and pancreas disease. Pancreatology. 2008;8(4-5):425-429.

7. Halangk W, Lerch MM, Brandt-Nedelev B, et al. Role of cathep-sin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest. 2000;106(6):773-781.

8. Tolstrup JS, Kristiansen L, Becker U, Grønbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med. 2009;169(6):603-609.

9. Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169(11):1035-1045.

10. Sadr-Azodi O, Andrén-Sandberg Å, Orsini N, Wolk A. Cigarette smoking, smoking cessation and acute pancreatitis: a prospec-tive population-based study. Gut. 2012;61(2):262-267.

11. Gullo L, Cavicchi L, Tomassetti P, Spagnolo C, Freyrie A, D’Addato M. Effects of ischemia on the human pancreas. Gastroenterology. 1996;111(4):1033-1038.

12. Mithöfer K, Fernández-del Castillo C, Frick TW, et al. Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitis. Ann Surg. 1995;221(4):364-371.

13. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291(23):2865-2868.

14. Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379-2400.

15. Bollen TL, Singh VK, Maurer R, et al. A comparative evalu-ation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol. 2012;107(4):612-619.

16. Spanier BWM, Nio Y, van der Hulst RWM, Tuynman HARE, Dijkgraaf MGW, Bruno MJ. Practice and yield of early CT scan in acute pancreatitis: a Dutch Observational Multicenter Study. Pancreatology. 2010;10(2-3):222-228.

17. Corfield AP, Cooper MJ, Williamson RC, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet. 1985;2(8452):403-407.

18. Agarwal N, Pitchumoni CS. Simplified prognostic criteria in acute pancreatitis. Pancreas. 1986;1(1):69-73.

19. De Bernardinis M, Violi V, Roncoroni L, Boselli AS, Giunta A, Peracchia A. Discriminant power and information content of Ranson’s prognostic signs in acute pancreatitis: a meta-analytic study. Crit Care Med. 1999;27(10):2272-2283.

20. Yeung YP, Lam BYK, Yip AWC. APACHE system is better than Ranson system in the prediction of severity of acute pancreati-tis. Hepatobiliary Pancreat Dis Int. 2006;5(2):294-299.

21. Singh VK, Wu BU, Bollen TL, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104(4):966-971.

22. Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson’s, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010;105(2):435-441.

23. Fisher JM, Gardner TB. The “golden hours” of management in acute pancreatitis. Am J Gastroenterol. 2012;107(8):1146-115.

24. Mao E, Fei J, Peng Y, Huang J, Tang Y, Zhang SD. Investigation of distribution of bacteria and fungi in severe acute pancreatitis. Zhonghua Wai Ke Za Zhi. 2010;48(7):496-501.

25. de-Madaria E, Soler-Sala G, Sánchez-Payá J, et al. Influence of, fluid therapy on the prognosis of acute pancreatitis: a prospec-tive cohort study. Am J Gastroenterol. 2011;106(10):1843-1850.

26. Wall I, Badalov N, Baradarian R, Iswara K, Li JJ, Tenner S. Decreased mortality in acute pancreatitis related to early aggres-sive hydration. Pancreas. 2011;40(4):547-550.

27. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in


References2

critically ill patients. Cochrane Database Syst Rev. Issue 11. Art. No.: CD001208. DOI: 10.1002/14651858.CD001208.pub4.

28. Wu BU, Hwang JQ, Gardner TH, Repas K, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenteral Hepatol. 2011;9(8):710-717, e1.

29. Warndorf MG, Kurtzman JT, Bartel MJ, et al. Early fluid resus-citation reduces morbidity among patients with acute pancreati-tis. Clin Gastroenteral Hepatol. 2011;9(8):705-709.

30. Yi F, Ge L, Zhao J, et al. Meta-analysis: total parenteral nutrition versus total enteral nutrition in predicted severe acute pancre-atitis. Intern Med. 2012;51(6):523-530.

31. Petrov MS, Kukosh MV, Emelyanov NV. A Randomized con-trolled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition. Dig Surg. 2006;23(5-6):336-345.

32. Jacobson BC, Vander Vliet MB, Hughes MD, Maurer R, McManus K, Banks PA. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol. 2007;5(8):946-951.

33. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology Guideline: management of acute pancreatitis. Am J Gastronterol. 2013;108(9):1400-1416.

34. McClave SA, Chang WK, Dhaliwal R, Heyland DK. Nutrition support in acute pancreatitis: a systematic review of the litera-ture. J Parenter Enteral Nutr. 2006;30(2):143-156.

35. Eatock FC, Brombacher GD, Steven A, Imrie CW, McKay CJ, Carter R. Nasogastric feeding in severe acute pancreatitis may be practical and safe. Int J Pancreatol. 2000;28(1):23-29.

36. Eatock FC, Chong P, Menezes N, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol. 2005;100(2):432-439.

37. Isenmann R, Rünzi M, Kron M, Kahl S, Kraus D, Jung N. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126(4):997-1004.

38. Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis. Ann Surg. 2007;245(5):674-683.

39. Villatoro E, Mulla M, Larvin M. Antibiotic therapy for pro-phylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010, Issue 5. Art. No.: CD002941. DOI: 10.1002/14651858.CD002941.pub3.

40. Røkke O, Harbitz TB, Liljedal J, et al. Early treatment of severe pancreatitis with imipenem: a prospective randomized clinical trial. Scand J Gastroenterol. 2007;42(6):771-776.

41. Arguedas MR, Dupont AW, Wilcox CM. Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopan-creatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model. Am J Gastroenterol. 2001;96(10):2892-2899.

42. Moretti A, Papi C, Aratari A, Festa V, Tanga M, et al Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of randomized controlled trials. Dig Liver Dis. 2008;40(5): 379-385.

43. Fölsch UR, Nitsche R, Lüdtke R, Hilgers RA, Creutzfeldt W. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med. 1997;336(4): 237-242.

44. Petrov MS, Uchugina AF, Kukosh MV. Does endoscopic retro-grade cholangiopancreatography reduce the risk of local pan-creatic complications in acute pancreatitis? A systematic review and metaanalysis. Surg Endosc. 2008;22(11):2338-2343.

45. Aboulian A, Chan T, Yaghoubian A, et al. Early cholecystec-tomy safely decreases hospital stay in patients with mild gall-stone pancreatitis: a randomized prospective study. Ann Surg. 2010;251(4):615-619.

46. Uhl W. Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease. Surg Endosc. 1999;13(11):1070-1076.

47. Wu BU, Banks PA. Clinical management of patients with acute pancreatitis. Gastroenterology. 2013;144(6):1272-1281.

48. Chen J, Fukami N, Li Z. Endoscopic approach to pancreatic pseudocyst, abscess and necrosis: review on recent progress. Dig Endosc. 2012;24(5):299-308.

49. Seifert H, Wehrmann T, Schmitt T, Zeuzem S, Caspary WF. Retroperitoneal endoscopic debridement for infected peripan-creatic necrosis. Lancet. 2000;356(9230):653-655.

50. Gardner TB, Coelho-Prabhu N, Gordon SR, et al. Direct endo-scopic necrosectomy for the treatment of walled-off pancreatic necrosis: results from a multicenter U.S. series. Gastrointest Endosc. 2011;73(4):718-726.

51. Takahashi N, Papachristou GI, Schmit GD, Chahal P, et al. CT findings of walled-off pancreatic necrosis (WOPN): differentiation from pseudocyst and prediction of outcome after endoscopic therapy—Springer. Eur Radiol. 2008;18(11): 2522-2529.

52. Bakker OJ, van Santvoort HC, van Brunschot S, et al. Endoscopic transgastric vs surgical necrosectomy for infected necrotiz-ing pancreatitis: a randomized trial. JAMA. 2012;307(10): 1053-1061.

53. van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362(16):1491-1502.

54. Freeman ML, Werner J, van Santvoort HC, et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas. 2012;41(8):1176-1194.


Chapter 109

REFERENCES

1. Bjorck M, Acosta S, Lindberg F, et al. Revascularization of the superior mesenteric artery after acute thromboembolic occlu-sion. Br J Surg. 2002;89:923.

2. Endean ED, Barnes SL, Kwolek CJ, et al. Surgical management of thrombotic acute intestinal ischemia. Ann Surg. 2001;233:801.

3. Foley MI, Moneta GL, Abou-Zamzam AM Jr, et al. Revascularization of the superior mesenteric artery alone for treatment of intestinal ischemia. J Vasc Surg. 2000;32:37.

4. Croft RJ, Menon GP, Marston A. Does “intestinal angina” exist? A critical study of obstructed visceral arteries. Br J Surg. 1981;68:316.

5. Park WM, Anner H, Paterson IS, et al. Contemporary man-agement of acute mesenteric ischemia: factors associated with survival. J Vasc Surg. 2002;35:445.

6. Chou CC, Hsieh CP, Yu YM, et al. Localization of mesenteric hyperemia during digestion in dogs. Am J Physiol. 1976;230:583.

7. Matheson PJ, Wilson MA, Garrison RN. Regulation of intestinal blood flow. J Surg Res. 2000;93:182.

8. Toung T, Reilly PM, Fuh KC, et al. Mesenteric vasoconstriction in response to hemorrhagic shock. Shock. 2000;13:267.

9. Donald DE, Shepherd JT. Autonomic regulation of the periph-eral circulation. Annu Rev Physiol. 1980;42:429.

10. Gallavan RH Jr, Chou CC, Kvietys PR, Sit SP. Regional blood flow during digestion in the conscious dog. Am J Physiol. 1980;238:H220.

11. Granger DN, Parks DA. Role of oxygen radicals in the patho-genesis of intestinal ischemia. Physiologist. 1983;26:159.

12. Granger DN, McCord JM, Parks DA, Hollwarth ME. Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterology. 1986;90:80.

13. Parks DA, Shah AK, Granger DN. Oxygen radicals: effects on intestinal vascular permeability. Am J Physiol. 1984;247:G167.

14. Carden DL, Young JA, Granger DN. Pulmonary microvascular injury after intestinal ischemia-reperfusion: role of P-selectin. J Appl Physiol. 1993;75:2529.

15. Jerome SN, Akimitsu T, Korthuis RJ. Leukocyte adhesion, edema, and development of postischemic capillary no-reflow. Am J Physiol. 1994;267:H1329.

16. Fine J. The present status of the problem of endotoxin shock. J Okla State Med Assoc. 1966;59:419.

17. Bennion RS, Wilson SE, Serota AI, Williams RA. The role of gastrointestinal microflora in the pathogenesis of complications of mesenteric ischemia. Rev Infect Dis. 1984;6(suppl 1):S132.

18. Klausner JM, Anner H, Paterson IS, et al. Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg. 1988;208:761.

19. Levy PJ, Krausz MM, Manny J. Acute mesenteric ischemia: improved results: a retrospective analysis of ninety-two patients. Surgery. 1990;107:372.

20. Huang HH, Hu SC, Yen DH, et al. The clinical factors and outcomes in patients with acute mesenteric ischemia in the emergency department. Acad Emerg Med. 2003;10:499.

21. Trompeter M, Brazda T, Remy CT, et al. Non-occlusive mesen-teric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2002;12:1179.

22. Thomas JH, Blake K, Pierce GE, et al. The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg. 1998;27:840.

23. Lock G, Scholmerich J. Non-occlusive mesenteric ischemia. Hepatogastroenterology. 1995;42:234.

24. Sudhakar CB, Al Hakeem M, MacArthur JD, Sumpio BE. Mesenteric ischemia secondary to cocaine abuse: case reports and literature review. Am J Gastroenterol. 1997;92:1053.

25. Valentine RJ, Hagino RT, Jackson MR, et al. Gastrointestinal complications after aortic surgery. J Vasc Surg. 1998;28:404.

26. Muraki SS, Fukada JJ, Morishita KK, et al. Acute type aortic dissection with intestinal ischemia predicted by serum lactate elevation. Ann Thorac Cardiovasc Surg. 2003;9:79.

27. Taylor BM, Jamieson WG, Durand D. Preinfarction diagnosis of acute mesenteric ischemia by simple measurement of inorganic phosphate in body fluids. Can J Surg. 1979;22:40.

28. Gearhart SL, Delaney CP, Senagore AJ, et al. Prospective assess-ment of the predictive value of alpha-glutathione-S- transferase for intestinal ischemia. Am Surg. 2003;69:324.

29. Murray MJ, Gonze MD, Nowak LR, Cobb CF. Serum d(–)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg. 1994;167:575.

30. DeLuca SA, Rhea JT. Bowel edema due to acute mesenteric ischemia. Am Fam Phys. 1982;25:175.

31. Zwolak RM. Can duplex ultrasound replace arteriography in screening for mesenteric ischemia? Semin Vasc Surg. 1999;12:252.


References2

32. Chou CK. CT manifestations of bowel ischemia. AJR. 2002;178:87.

33. Hagspiel KD, Leung DA, Angle JF, et al. MR angiography of the mesenteric vasculature. Radiol Clin North Am. 2002;40:867.

34. Heiss SG, Li KC. Magnetic resonance angiography of mesen-teric arteries: a review. Invest Radiol. 1998;33:670.

35. Laissy JP, Trillaud H, Douek P. MR angiography: noninvasive vascular imaging of the abdomen. Abdom Imaging. 2002;27:488.

36. Clark RA, Gallant TE. Acute mesenteric ischemia: angiographic spectrum. AJR. 1984;142:555.

37. Lefkovitz Z, Cappell MS, Lookstein R, et al. Radiologic diagno-sis and treatment of gastrointestinal hemorrhage and ischemia. Med Clin North Am. 2002;86:1357.

38. Boos S. Angiography of the mesenteric artery 1976 to 1991: a change in the indications during mesenteric circulatory disor-ders? Radiologe. 1992;32:154.

39. Morano JU, Harrison RB. Mesenteric ischemia: angiographic diagnosis and intervention. Clin Imaging. 1991;15:91.

40. Kaleya RN, Boley SJ. Acute mesenteric ischemia: an aggressive diagnostic and therapeutic approach. 1991 Roussel Lecture. Can J Surg. 1992;35:613.

41. MacCannell KL. Comparison of an intravenous selective mesenteric vasodilator with intraarterial papaverine in experi-mental nonocclusive mesenteric ischemia. Gastroenterology. 1986;91:79.

42. VanDeinse WH, Zawacki JK, Phillips D. Treatment of acute mesenteric ischemia by percutaneous transluminal angioplasty. Gastroenterology. 1986;91:475.

43. Rundback JH, Rozenblat GN, Poplausky M. Re: jejunal artery angioplasty and coronary stent placement for acute mesenteric ischemia. Cardiovasc Intervent Radiol. 2000;23:410.

44. Senechal Q, Massoni JM, Laurian C, Pernes JM. Transient relief of abdominal angina by Wallstent placement into an occluded superior mesenteric artery. J Cardiovasc Surg (Torino). 2001;42:101.

45. Orlando R III, Crowell KL. Laparoscopy in the critically ill. Surg Endosc. 1997;11:1072.

46. Zamir G, Reissman P. Diagnostic laparoscopy in mesenteric ischemia. Surg Endosc. 1998;12:390.

47. Gagne DJ, Malay MB, Hogle NJ, Fowler DL. Bedside diag-nostic minilaparoscopy in the intensive care patient. Surgery. 2002;131:491.

48. Regan F, Karlstad RR, Magnuson TH. Minimally invasive man-agement of acute superior mesenteric artery occlusion: com-bined urokinase and laparoscopic therapy. Am J Gastroenterol. 1996;91:1019.

49. Kazmers A. Operative management of acute mesenteric isch-emia, part 1. Ann Vasc Surg. 1998;12:187.

50. Bulkley GB, Zuidema GD, Hamilton SR, O’Mara CS, Klacsmann PG, Horn SD. Intraoperative determination of small intes-tinal viability following ischemic injury: a prospective, con-trolled trial of two adjuvant methods (Doppler and fluorescein) compared with standard clinical judgment. Ann Surg. 1981; 193:628.

51. Batellier J, Kieny R. Superior mesenteric artery embolism: eighty-two cases. Ann Vasc Surg. 1990;4:112.

52. Ballard JL, Stone WM, Hallett JW, et al. A critical analysis of adjuvant techniques used to assess bowel viability in acute mesenteric ischemia. Am Surg. 1993;59:309.

53. Sullivan KM, Battey PM, Miller JS, et al. Abdominal compart-ment syndrome after mesenteric revascularization. J Vasc Surg. 2001;34:559.

54. Edwards MS, Cherr GS, Craven TE, et al. Acute occlusive mes-enteric ischemia: surgical management and outcomes. Ann Vasc Surg. 2003;17:72.

55. Cho JS, Carr JA, Jacobsen G, Shepard AD, Nypaver TJ, Reddy DJ. Long-term outcome after mesenteric artery recon-struction: a 37-year experience. J Vasc Surg. 2002;35:453.

56. Johnston KW, Lindsay TF, Walker PM, Kalman PG. Mesenteric arterial bypass grafts: early and late results and suggested surgical approach for chronic and acute mesenteric ischemia. Surgery. 1995;118:1.

57. Laghi A, Iannaccone R, Catalano C, Passariello R. Multislice spiral computed tomography angiography of mesenteric arter-ies. Lancet. 2001;358:638.

58. Bowdish ME, Weaver FA, Liebman HA, et al. Anticoagulation is an effective treatment for aortic mural thrombi. J Vasc Surg. 2002;36:713.

59. Keller HW, Lorenz R, Müller JM. Ischemic colitis following digitalis intoxication. Chirurg. 1984;55:830-831.

60. Kauffmann GW, Friedburg H, Anger P, Rückauer K. Diagnosis, differential diagnosis, and management of so-called “non-occlusive disease”. Chirurg. 1982;53:641-645.

61. Stöckmann H, Roblick UJ, Kluge N, et al. Diagnosis and treat-ment of non-occlusive mesenteric ischemia. Zentralbl Chir. 2000;125(2):144-151.

62. Bruch H-P, Broll R, Wünsch P, Schindler G. The problem of non-occlusive ischemic enteropathy (NOMI): Diagnosis, therapy, and prognosis. Chirurg. 1989;60:419-425.

63. Kolkmann JJ, Groeneveld ABJ. Occlusive and non-occlusive gastrointestinal ischaemia: a clinical review with special empha-sis on the diagnostic value of tonometry. Scand J Gastroenterol. 1998;33(suppl 225):3-12.

64. Kniemeyer HW. Mesenteric infarction: when is a vascular sur-geon needed? Zentralbl Chir. 1998;123:1411-1417.

65. Acosta S, Nilsson T. Current status on plasma biomarkers for acute mesenteric ischemia. J Thromb Thrombolysis. May 2012;33(4):355-361.

66. Akyildiz H, Akcan A, Oztürk A, Sozuer E, Kucuk C, Karahan I. The correlation of the D-dimer test and biphasic computed tomography with mesenteric computed tomography angiogra-phy in the diagnosis of acute mesenteric ischemia. Am J Surg. April 2009;197(4):429-433.

67. Oliva IB, Davarpanah AH, Rybicki FJ, et al. ACR appropriate-ness criteria(®) imaging of mesenteric ischemia. Abdom Imaging. January 9, 2013. [Epub ahead of print] PMID:23296712.

68. Liem TK, Segall JA, Wei W, Landry GH, Taylor LM, Moneta GL. J Vasc Surg. 2007;45(5):922-928.

69. Milner R, Woo EY, Carpenter JP. Superior mesenteric artery angioplasty and stenting via a retrograde approach in a patient with bowel ischemia—a case report. Vasc Endovasc Surg. 2004;38:89-91.


References 3

70. Wyers MC, Powell RJ, Nolan BW, Cronenwett JL. Retrograde mesenteric stenting during laparotomy for acute occlusive mes-enteric ischemia. J Vasc Surg. 2007;45:269-275.

71. Gupta PK, Natarajan B, Gupta H, Fang X, Fitzgibbons RJ Jr. Morbidity and mortality after bowel resection for acute mesen-teric ischemia. Surgery. October 2011;150(4):779-787.

72. Ryer EJ, Kalra M, Oderich GS, et al. Revascularization for acute mesenteric ischemia. J Vasc Surg. June 2012;55(6):1682-1689.

73. Newton WB III, Sagransky MJ, Andrews JS, et al. Outcomes of revascularized acute mesenteric ischemia in the American College of Surgeons National Surgical Quality Improvement Program. Am Surg. July 2011;77(7):832-838.

74. Rawat N, Gibbons CP; Joint Vascular Research Group. Surgical or endovascular treatment for chronic mesenteric ischemia: a multicenter study. Ann Vasc Surg. October 2010;24(7):935-945.


Chapter 104 · Chapter 104 Jaundice, Diarrhea, ... role of ERCP in diseases of the biliary tract...

Documents

Transcript of Chapter 104 · Chapter 104 Jaundice, Diarrhea, ... role of ERCP in diseases of the biliary tract...